Ipamorelin – Research Peptide

Ipamorelin is a synthetic pentapeptide designed for use in controlled laboratory environments to study selective growth hormone secretagogue (GHSR) receptor activity, intracellular signalling cascades, and peptide–receptor specificity.
It is widely used in research settings to compare short-acting secretagogue analogues and evaluate isolated pathway responses under strictly regulated conditions.

This compound is supplied strictly as a research-use-only (RUO) reference material and is not intended for human or veterinary use.

Product Information

Overview

Ipamorelin is a highly selective pentapeptide agonist of the GHSR (growth hormone secretagogue receptor), allowing researchers to isolate and analyse targeted receptor pathways with minimal off-target interaction.
Its selectivity makes it a valuable tool compound in endocrine signalling studies, comparative peptide modelling, and receptor-specific downstream cascade analysis.

Studies frequently utilise Ipamorelin to evaluate kinetic behaviour, receptor occupancy, and signalling strength in controlled experimental conditions.
Its short-acting nature makes it ideal for examining transient peptide exposure and pulsatile signalling models.

Potential Research Applications

• Selective GHSR receptor activation models
• Peptide–receptor binding specificity studies
• Short-acting vs. long-acting secretagogue comparison
• Intracellular signalling cascade mapping
• Endocrine pathway modulation in non-clinical assays
• Pharmacokinetic and binding-affinity experiments

Scientific Background

Ipamorelin is part of a class of peptides designed to selectively target the ghrelin receptor (GHSR-1a) without influencing other hormonal pathways often triggered by earlier secretagogues.
Preclinical analyses have explored its potency, receptor selectivity, and effect on downstream JAK/STAT and cAMP-related signalling in laboratory models.

Key areas of study include:

• receptor-selective peptide engineering
• comparisons with hexapeptides such as GHRP-6 and GHRP-2
• time-dependent receptor desensitisation behaviour
• binding-site affinity mapping

All investigations are carried out in controlled experimental environments and do not relate to clinical or therapeutic use.

Safety and Handling

Ipamorelin is intended solely for use by qualified professionals in appropriate laboratory facilities. Standard PPE is recommended when handling this peptide.

• Avoid ingestion, inhalation, or contact with skin and eyes.
• Handle using standard chemical safety procedures.
• Dispose of all unused material according to local laboratory peptide-waste regulations.

This peptide must not be used for human or veterinary administration. No therapeutic or dietary use is permitted or implied.

Disclaimer

All information provided is for scientific and educational reference only. Ipamorelin from Adonis Elite Peptides is supplied strictly as a research-use-only (RUO) laboratory reagent.

It is not a drug, medicine, or product for human or veterinary use. End-users are responsible for ensuring compliance with all applicable regional regulations regarding the purchase and handling of research materials.